Improving arterial prosthesis neo-endothelialization: Application of a proactive VEGF construct onto PTFE surfaces

被引:77
作者
Crombez, M
Chevallier, P
Gaudreault, RC
Petitclerc, E
Mantovani, D
Laroche, G [1 ]
机构
[1] Univ Laval, Fac Sci & Genie, Dept Genie Mines Met & Mat, Ste Foy, PQ G1K 7P4, Canada
[2] Univ Laval, Fac Med, Dept Med, Ste Foy, PQ G1K 7P4, Canada
[3] CHUQ, Hop St Francois, Ctr Rech, Unite Biotechnol & Bioingn, Quebec City, PQ G1L 3L5, Canada
关键词
vascular endothelial growth factor; surface modification; endothelial cells; plasma treatment;
D O I
10.1016/j.biomaterials.2005.05.051
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The formation of a confluent endothelium on expanded polytetrafluoroethylene (PTFE) vascular prostheses has never been observed. This lack of endothelialization is known to be one of the main reasons leading to the development of thromboses and/or intimal hyperplasia. In this context, several efforts were put forward to promote endothelial cell coverage on the internal surface of synthetic vascular prostheses. The goal of the present study was to immobilize the vascular endothelial growth factor (VEGF) onto Teflon (R) PTFE surfaces to generate a proactive polymer construct favoring interaction with endothelial cells. An ammonia plasma treatment was first used to graft amino groups on PTFE films. Subsequent reactions were performed to covalently bind human serum albumin (HSA) on the polymer surface and to load this protein with negative charges, which allows adsorbtion of VEGF onto HSA via strong electrostatic interactions. X-ray photoelectron spectroscopy (XPS) experiments along with surface derivatization strategies were performed between each synthesis step to ascertain the occurrence of the various molecules surface immobilization. Finally, the electrostatic binding of VEGF to the negatively charged HSA matrix was performed and validated by ELISA. Endothelial cell adhesion and migration experiments were carried out to validate the potential of this VEGF-containing biological construct to act as a proactive media toward the development of endothelial cells. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:7402 / 7409
页数:8
相关论文
共 32 条
[1]   LOCAL-DELIVERY OF VASCULAR ENDOTHELIAL GROWTH-FACTOR ACCELERATES REENDOTHELIALIZATION AND ATTENUATES INTIMAL HYPERPLASIA IN BALLOON-INJURED RAT CAROTID-ARTERY [J].
ASAHARA, T ;
BAUTERS, C ;
PASTORE, C ;
KEARNEY, M ;
ROSSOW, S ;
BUNTING, S ;
FERRARA, N ;
SYMES, JF ;
ISNER, JM .
CIRCULATION, 1995, 91 (11) :2793-2801
[2]   INTERACTION OF VASCULOTROPIN VASCULAR ENDOTHELIAL-CELL GROWTH-FACTOR WITH HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS - BINDING, INTERNALIZATION, DEGRADATION, AND BIOLOGICAL EFFECTS [J].
BIKFALVI, A ;
SAUZEAU, C ;
MOUKADIRI, H ;
MACLOUF, J ;
BUSSO, N ;
BRYCKAERT, M ;
PLOUET, J ;
TOBELEM, G .
JOURNAL OF CELLULAR PHYSIOLOGY, 1991, 149 (01) :50-59
[3]   Effect of FGF-1 and FGF-2 on VEGF binding to human umbilical vein endothelial cells [J].
Chen, JH ;
Wang, XC ;
Kan, MK ;
Sato, JD .
CELL BIOLOGY INTERNATIONAL, 2001, 25 (03) :257-260
[4]   Ammonia RF-plasma on PTFE surfaces: Chemical characterization of the species created on the surface by vapor-phase chemical derivatization [J].
Chevallier, P ;
Castonguay, N ;
Turgeon, S ;
Dubrulle, N ;
Mantovani, D ;
McBreen, PH ;
Wittmann, JC ;
Laroche, G .
JOURNAL OF PHYSICAL CHEMISTRY B, 2001, 105 (50) :12490-12497
[5]   PERIPHERAL ARTERIAL-DISEASE IN LARGE VESSELS IS EPIDEMIOLOGICALLY DISTINCT FROM SMALL VESSEL DISEASE - AN ANALYSIS OF RISK-FACTORS [J].
CRIQUI, MH ;
BROWNER, D ;
FRONEK, A ;
KLAUBER, MR ;
COUGHLIN, SS ;
BARRETTCONNOR, E ;
GABRIEL, S .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1989, 129 (06) :1110-1119
[6]   Vascular endothelial growth factor inhibits mitogen-induced vascular smooth muscle cell proliferation [J].
Dorafshar, AH ;
Angle, N ;
Bryer-Ash, M ;
Huang, DS ;
Farooq, MM ;
Gelabert, HA ;
Freischlag, JA .
JOURNAL OF SURGICAL RESEARCH, 2003, 114 (02) :179-186
[7]   Solution structure of the heparin-binding domain of vascular endothelial growth factor [J].
Fairbrother, WJ ;
Champe, MA ;
Christinger, HW ;
Keyt, BA ;
Starovasnik, MA .
STRUCTURE WITH FOLDING & DESIGN, 1998, 6 (05) :637-648
[8]   The biology of vascular endothelial growth factor [J].
Ferrara, N ;
DavisSmyth, T .
ENDOCRINE REVIEWS, 1997, 18 (01) :4-25
[9]   Molecular and biological properties of vascular endothelial growth factor [J].
Ferrara, N .
JOURNAL OF MOLECULAR MEDICINE-JMM, 1999, 77 (07) :527-543
[10]   Role of vascular endothelial growth factor in regulation of physiological angiogenesis [J].
Ferrara, N .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2001, 280 (06) :C1358-C1366